Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 1
1968 4
1969 3
1970 4
1971 2
1972 3
1973 9
1974 5
1975 6
1976 14
1977 6
1978 5
1979 10
1980 7
1981 10
1982 10
1983 24
1984 18
1985 21
1986 29
1987 36
1988 37
1989 30
1990 50
1991 48
1992 45
1993 46
1994 48
1995 45
1996 47
1997 40
1998 41
1999 47
2000 36
2001 37
2002 44
2003 58
2004 57
2005 40
2006 65
2007 45
2008 70
2009 68
2010 73
2011 84
2012 100
2013 115
2014 124
2015 110
2016 99
2017 105
2018 102
2019 121
2020 119
2021 107
2022 108
2023 102
2024 108
2025 115
2026 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,718 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
The following term was not found in PubMed: anatoxinum
Page 1
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis.
Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Del Corpo O, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM, Loeb M, Lee TC. Bai AD, et al. Clin Microbiol Infect. 2022 Aug;28(8):1076-1084. doi: 10.1016/j.cmi.2022.03.015. Epub 2022 Mar 23. Clin Microbiol Infect. 2022. PMID: 35339678 Free article.
BACKGROUND: Precise estimates of mortality in Staphylococcus aureus bacteraemia (SAB) are important to convey prognosis and guide the design of interventional studies. ...
BACKGROUND: Precise estimates of mortality in Staphylococcus aureus bacteraemia (SAB) are important to convey prognosis and guide the …
Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus.
Kato H, Hagihara M, Asai N, Shibata Y, Koizumi Y, Yamagishi Y, Mikamo H. Kato H, et al. J Glob Antimicrob Resist. 2021 Mar;24:98-105. doi: 10.1016/j.jgar.2020.12.009. Epub 2021 Jan 2. J Glob Antimicrob Resist. 2021. PMID: 33401013 Free article.
OBJECTIVE: American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines suggest that linezolid (LZD) is preferred over vancomycin (VCM) for treating methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. We conducted a systematic review and …
OBJECTIVE: American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines suggest that linezolid (LZD) is preferred …
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Geriak M, Haddad F, Rizvi K, Rose W, Kullar R, LaPlante K, Yu M, Vasina L, Ouellette K, Zervos M, Nizet V, Sakoulas G. Geriak M, et al. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e02483-18. doi: 10.1128/AAC.02483-18. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30858203 Free PMC article. Clinical Trial.
Vancomycin (VAN) and daptomycin (DAP) are approved as a monotherapy for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. A regimen of daptomycin plus ceftaroline (DAP+CPT) has shown promise in published case series of MRSA salvage therapy, but no comparative …
Vancomycin (VAN) and daptomycin (DAP) are approved as a monotherapy for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia …
Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
Mourad A, Nwafo N, Skalla L, Holland TL, Jenkins TC. Mourad A, et al. Clin Infect Dis. 2025 Feb 5;80(1):29-36. doi: 10.1093/cid/ciae476. Clin Infect Dis. 2025. PMID: 39290168 Free article.
BACKGROUND: We conducted a systematic review of randomized, controlled trials (RCTs) to generate more precise estimates of the efficacy and safety of oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis. METHODS: MEDLINE, Embase, …
BACKGROUND: We conducted a systematic review of randomized, controlled trials (RCTs) to generate more precise estimates of the efficacy and …
Ceftaroline.
Soriano A. Soriano A. Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):29-31. doi: 10.37201/req/s01.08.2021. Epub 2021 Sep 30. Rev Esp Quimioter. 2021. PMID: 34598420 Free PMC article. Review.
Ceftaroline is a fifth-generation cephalosporin with a potent In vitro activity against Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus, the three most important pathogens causing CAP. Three randomized and double-blind clinical trials compared th …
Ceftaroline is a fifth-generation cephalosporin with a potent In vitro activity against Streptococcus pneumoniae, Haemophilus influenzae and …
Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
Prosty C, Noutsios D, Lee TC, Daneman N, Davis JS, Jager NGL, Ghanem-Zoubi N, Goodman AL, Kaasch AJ, Kouijzer I, McMullan BJ, McDonald EG, Tong SYC, Ong SWX; Staphylococcus aureus Network Adaptive Platform MSSA/PSSA domain specific working group. Prosty C, et al. Clin Microbiol Infect. 2025 Aug;31(8):1272-1282. doi: 10.1016/j.cmi.2025.04.045. Epub 2025 May 9. Clin Microbiol Infect. 2025. PMID: 40349971 Free article.
BACKGROUND: There is debate on whether cefazolin or antistaphylococcal penicillins should be the first-line treatment for methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia. Ongoing trials are investigating whether cefazolin is non-inferior to (flu)cloxacilli …
BACKGROUND: There is debate on whether cefazolin or antistaphylococcal penicillins should be the first-line treatment for methicillin-suscep …
Regulatory effects of Lactobacillus plantarum-GMNL6 on human skin health by improving skin microbiome.
Tsai WH, Chou CH, Chiang YJ, Lin CG, Lee CH. Tsai WH, et al. Int J Med Sci. 2021 Jan 1;18(5):1114-1120. doi: 10.7150/ijms.51545. eCollection 2021. Int J Med Sci. 2021. PMID: 33526970 Free PMC article. Clinical Trial.
Meanwhile, L. plantarum-GMNL6 reduced the melanin synthesis, the biofilm of Staphylococcus aureus, and the proliferation of Cutibacterium acnes. Information from clinical observation during the ointment for external face use in people displayed that the syndromes of skin m …
Meanwhile, L. plantarum-GMNL6 reduced the melanin synthesis, the biofilm of Staphylococcus aureus, and the proliferation of Cutibacte …
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial.
Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, Salem SS, Brinton SL, Rudman Spergel AK, Johnson K, Jepson B, Calatroni A, David G, Ramirez-Gama M, Taylor P, Leung DYM, Gallo RL. Nakatsuji T, et al. Nat Med. 2021 Apr;27(4):700-709. doi: 10.1038/s41591-021-01256-2. Epub 2021 Feb 22. Nat Med. 2021. PMID: 33619370 Free PMC article. Clinical Trial.
Staphylococcus aureus colonizes patients with atopic dermatitis (AD) and exacerbates disease by promoting inflammation. The present study investigated the safety and mechanisms of action of Staphylococcus hominis A9 (ShA9), a bacterium isolated from healthy human sk …
Staphylococcus aureus colonizes patients with atopic dermatitis (AD) and exacerbates disease by promoting inflammation. The present s …
Antibiotic synergy against Staphylococcus aureus: a systematic review and meta-analysis.
Mellett M, Lawandi A, Caya C, Lee TC, Babiker A, Papenburg J, Yansouni CP, Cheng MP. Mellett M, et al. Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0119924. doi: 10.1128/aac.01199-24. Epub 2025 Jun 17. Antimicrob Agents Chemother. 2025. PMID: 40526084 Free PMC article.
Despite the available literature, no studies comprehensively summarize the findings for antimicrobial combinations against Staphylococcus aureus. We performed a systematic review to identify synergistic combinations that may be beneficial for clinical use against S. aureus …
Despite the available literature, no studies comprehensively summarize the findings for antimicrobial combinations against Staphylococcus …
Rapid Screening of Methicillin-Resistant Staphylococcus aureus Using MALDI-TOF MS and Machine Learning: A Randomized, Multicenter Study.
Yong D, Park JS, Kim K, Seo D, Kim DC, Kim JS, Park JM. Yong D, et al. Anal Chem. 2025 Jul 29;97(29):15667-15675. doi: 10.1021/acs.analchem.5c01286. Epub 2025 Jul 15. Anal Chem. 2025. PMID: 40665608 Free PMC article. Clinical Trial.
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections including bacteremia. ...
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections including bacteremia. ...
2,718 results